TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Eyenovia, Inc. (NASDAQ: EYEN) Investor Investigation Over Potential Securities Laws Violations Announced

  • Investors who purchased shares of Eyenovia, Inc. (NASDAQ: EYEN), have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Eyenovia, Inc.
Security
NASDAQ: EYEN

Summary

An investigation on behalf of investors of Eyenovia, Inc. (NASDAQ: EYEN) shares over potential securities laws violations by Eyenovia, Inc. and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Eyenovia, Inc. (NASDAQ: EYEN) concerning whether a series of statements by Eyenovia, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

New York based Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. Eyenovia, Inc. went public in January 2018. Since then shares of Eyenovia, Inc. (NASDAQ: EYEN) declined from $10.74 per share on January 25, 2018 to as low as $7.63 per share on May 25, 2018.

Start Monitoring Your Investments